Inspire Medical Systems (INSP) Depreciation & Amortization (CF) (2017 - 2026)

Inspire Medical Systems has disclosed Depreciation & Amortization (CF) across 10 years of filings, most recently posting $5.1 million for Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $5.1 million, up 67.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.0 million (up 83.02% YoY), and the FY2025 annual result was $14.0 million, up 113.08% from the prior year.
• Depreciation & Amortization (CF) came in at $5.1 million for Q1 2026 at Inspire Medical Systems, up from $3.8 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $5.1 million in Q1 2026 to a low of $359000.0 in Q1 2022.
• The 5-year median for Depreciation & Amortization (CF) is $839000.0 (2024), against an average of $1.8 million.
• Across the five-year window, Depreciation & Amortization (CF) soared 37.17% in 2022 and jumped 262.81% in 2025, its largest moves.
• Inspire Medical Systems' Depreciation & Amortization (CF) stood at $569000.0 in 2022, then jumped by 43.59% to $817000.0 in 2023, then soared by 203.3% to $2.5 million in 2024, then jumped by 54.24% to $3.8 million in 2025, then jumped by 33.7% to $5.1 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $5.1 million (Q1 2026), $3.8 million (Q4 2025), and $3.7 million (Q3 2025), per Business Quant data.